"Mater Private Hospital Brisbane has been supporting Queenslanders’ health since 1906. Over the years we’ve evolved from a modest, 20-bed facility into a world-class, 323 bed hospital featuring 10 operating theatres, a 24 hour private emergency service and over 35 specialised clinical services."

During the past decade, Mater Private Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mater Private Hospital" #1 collaborator was "ANZICS Clinical Trials Group" with 2 trials as a collaborator, "Medical Research Institute of New Zealand" with 2 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator and "Colorectal Surgical Society of Australasia (CSSA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Mater Private Hospital" are "Breast Cancer" (2 trials), "Adenocarcinoma of Rectum" (1 trials), "Advanced Breast Cancer" (1 trials), "Critically Ill" (1 trials) and "Critically Ill, Mechanically Ventilated" (1 trials). Many other conditions were trialed in "Mater Private Hospital" in a lesser frequency.

Most popular intervention types in "Mater Private Hospital" are "Drug" (3 trials), "Behavioral" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "Neratinib" (2 trials), "Concurrent Chemotherapy" (1 trials), "Early activity and Mobilisation Intervention" (1 trials) and "Early activity and mobilisation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mater Private Hospital" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mater Private Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Mater Private Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mater Private Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".